Yaben Chemical's Shangyu base will produce 'anti-aging drugs'

On July 17, an investor asked Yaben Chemical whether it was true that the company had completed the relevant procedures for nmn.

Yaben Chemical responded that the NMN project is one of the company's Shangyu base enzyme preparation and API projects. Currently, the Shangyu base is under construction, and the company will disclose relevant information in accordance with laws and regulations.

NMN is called β-nicotinamide mononucleotide, which is the precursor of NAD+ (coenzyme I) synthesis in the human body. Since NAD+ is a coenzyme for hundreds of important metabolic enzymes in cells, and as a signal molecule participates in many important cellular processes, it is closely related to energy metabolism, glycolysis, DNA replication and other activities, and NMN can increase the level of NAD+ in the body, which is considered It is a kind of health care product with anti-aging function, and some people simply call it "the elixir of life."

In the TOP10 list of 618 nutrition and health products third-party stores disclosed by JD.com, the first, second, sixth, and seventh places are all NMN-related health products. The emergence of NMN has caused the market. Restless, affected by this news, Yaben Chemical, as a concept stock, went out of 2 daily limits in 4 days.

Yaben Chemical is one of the few A-share listed companies that announced that they have NMN production technology. The company disclosed on October 11, 2019 that it plans to invest 450 million yuan in enzyme preparations and green research institute projects to develop and produce bio-enzyme preparations such as NMN and related biotech products.

According to the data, Yaben Chemical's main business is the research and development, production and sales of pesticide intermediates and pharmaceutical intermediates. It was listed on the Shenzhen Stock Exchange on September 6, 2011.